Tim O’Donnell

1.8k total citations
3 papers, 4 citations indexed

About

Tim O’Donnell is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Tim O’Donnell has authored 3 papers receiving a total of 4 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Immunology, 1 paper in Molecular Biology and 1 paper in Oncology. Recurrent topics in Tim O’Donnell's work include Immunotherapy and Immune Responses (3 papers), Cancer Immunotherapy and Biomarkers (1 paper) and Cancer Genomics and Diagnostics (1 paper). Tim O’Donnell is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), Cancer Immunotherapy and Biomarkers (1 paper) and Cancer Genomics and Diagnostics (1 paper). Tim O’Donnell collaborates with scholars based in United States. Tim O’Donnell's co-authors include Julia Kodysh, Marcia Meseck, Güray Aktürk, Philip Friedlander, Cansu Cimen Bozkus, Sacha Gnjatic, Thomas U. Marron, John P. Finnigan, Ryung S. Kim and Ana-Belén Blázquez and has published in prestigious journals such as Cancer Research, Neuro-Oncology and Regular and Young Investigator Award Abstracts.

In The Last Decade

Tim O’Donnell

3 papers receiving 4 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tim O’Donnell United States 2 4 2 1 1 1 3 4
Himayat Ullah Saudi Arabia 2 3 0.8× 3 1.5× 1 1.0× 8 9
Selma Erol Aytekin Türkiye 2 4 1.0× 1 1.0× 1 1.0× 4 6
Annemarie Gabrysch Germany 2 4 1.0× 1 1.0× 1 1.0× 2 5
Han Shuyu China 2 4 1.0× 1 1.0× 3 4
Gunilla Karlsson Hedestam Sweden 2 4 1.0× 4 2.0× 1 1.0× 2 7
Marie Materna Iran 1 5 1.3× 1 1.0× 3 6
Seng Kuong Anakin Ung United Kingdom 2 3 0.8× 1 1.0× 1 1.0× 2 4
C. G. Zhu China 2 3 0.8× 3 6
O. Distler Belgium 2 3 0.8× 2 3
H. Badran Finland 2 3 0.8× 3 5

Countries citing papers authored by Tim O’Donnell

Since Specialization
Citations

This map shows the geographic impact of Tim O’Donnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim O’Donnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim O’Donnell more than expected).

Fields of papers citing papers by Tim O’Donnell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim O’Donnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim O’Donnell. The network helps show where Tim O’Donnell may publish in the future.

Co-authorship network of co-authors of Tim O’Donnell

This figure shows the co-authorship network connecting the top 25 collaborators of Tim O’Donnell. A scholar is included among the top collaborators of Tim O’Donnell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim O’Donnell. Tim O’Donnell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

3 of 3 papers shown
1.
Bozkus, Cansu Cimen, Julia Kodysh, Simon K. Cheng, et al.. (2024). CTIM-10. PHASE 1 TRIAL OF PERSONALIZED NEOANTIGEN VACCINES IN COMBINATION WITH STANDARD CARE TO TREAT GLIOBLASTOMA. Neuro-Oncology. 26(Supplement_8). viii86–viii87. 1 indexed citations
2.
Kodysh, Julia, Cansu Cimen Bozkus, Mansi Saxena, et al.. (2021). 334 Phase I study of safety and activity of personalized neoantigen-based vaccines in combination with tumor treating fields for newly diagnosed glioblastoma patients. Regular and Young Investigator Award Abstracts. A360–A360. 2 indexed citations
3.
Kodysh, Julia, Thomas U. Marron, Alex Rubinsteyn, et al.. (2020). Abstract CT173: PGV-001: A phase I trial of a multipeptide personalized neoantigen vaccine in the adjuvant setting. Cancer Research. 80(16_Supplement). CT173–CT173. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026